83 related articles for article (PubMed ID: 3488968)
1. The immune system during the pre-cancer and the early cancer period. IL-2 production by PBL from post-menopausal women with and without endometrial carcinoma.
Yron I; Schickler M; Fisch B; Pinkas H; Ovadia J; Witz IP
Int J Cancer; 1986 Sep; 38(3):331-8. PubMed ID: 3488968
[TBL] [Abstract][Full Text] [Related]
2. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
Wanebo HJ; Pace R; Hargett S; Katz D; Sando J
Cancer; 1986 Feb; 57(3):656-62. PubMed ID: 3484660
[TBL] [Abstract][Full Text] [Related]
3. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
Soulillou JP; Douillard JY; Vie H; Harousseau JL; Guenel J; le Mevel-le Pourhiet A; le Mevel B
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):935-9. PubMed ID: 3876220
[TBL] [Abstract][Full Text] [Related]
4. Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells.
Rey A; Klein B; Zagury D; Thierry C; Serrou B
Immunol Lett; 1983 Mar; 6(3):175-8. PubMed ID: 6602761
[TBL] [Abstract][Full Text] [Related]
5. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes.
Miescher S; Whiteside TL; Carrel S; von Fliedner V
J Immunol; 1986 Mar; 136(5):1899-907. PubMed ID: 2936812
[TBL] [Abstract][Full Text] [Related]
6. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
7. Effect of thymic hormones on interleukin 2 synthesis by lymphocytes from HIV-positive pre-AIDS subjects.
Skotnicki AB; Zatz M; Sztein MB; Goldstein AL; Schulof RS
Immunol Invest; 1988 Apr; 17(2):159-64. PubMed ID: 3261713
[TBL] [Abstract][Full Text] [Related]
8. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
Hughes CC; Pober JS
J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of interleukin-2 production in human lymphocytes by two new quinolone derivatives.
Zehavi-Willner T; Shalit I
Lymphokine Res; 1989; 8(1):35-46. PubMed ID: 2785621
[TBL] [Abstract][Full Text] [Related]
10. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.
Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE
Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013
[TBL] [Abstract][Full Text] [Related]
12. Frequency and activity of autorosette forming cells in Con-A activated PBL from women with hyperplasia or carcinoma of the endometrium--possible role of estrogens.
Yron I; Kalechman Y; Langer A; Lidor I; Luria B; Luria H; Ovadia J; Pardo Y; Shohat L
J Clin Lab Immunol; 1990 Nov; 33(3):135-43. PubMed ID: 1967003
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes.
Vie H; Bonneville M; Cariou R; Moreau JF; Soulillou JP
Kidney Int; 1985 Sep; 28(3):553-7. PubMed ID: 3906228
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood lymphocyte response to exogenous interleukin 2 by PHA-prestimulated and non-PHA-prestimulated cells in patients with cancer.
Mantovani G; Coiana A; Cossu F; Floris C; Proto E; Macciò A; Pisano G; Taglieri G; Puxeddu G; Del Giacco GS
Tumori; 1986 Aug; 72(4):375-82. PubMed ID: 3490027
[TBL] [Abstract][Full Text] [Related]
16. [Immunological aspects of hyperplastic processes, precancerous conditions and cancer of the endometrium during the post-menopausal period].
Kadagidze ZG; Ivshina AV; Kuznetsov VA; Golukhov GN; Breusenko VG
Sov Med; 1988; (7):25-9. PubMed ID: 3265805
[No Abstract] [Full Text] [Related]
17. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
Meier P; Dayer E; Ronco P; Blanc E
Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
[TBL] [Abstract][Full Text] [Related]
18. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
19. In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis.
Vervliet G; Schandené L
Clin Exp Immunol; 1985 Sep; 61(3):556-61. PubMed ID: 3935348
[TBL] [Abstract][Full Text] [Related]
20. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
